Aims Intra-aortic balloon counterpulsation (IABP) in ST-segment elevation myocardial
infarction (STEMI) with cardiogenic shock is strongly recommended (class IB) in the current …

Aims Patient access to reperfusion therapy and the use of primary percutaneous coronary
intervention (p-PCI) or thrombolysis (TL) varies considerably between European countries …

Background: Despite advances in treatment, mortality in acute myocardial infarction (AMI)
complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory …

Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion
therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate …

Background—Discordance between fractional flow reserve (FFR) and coronary flow velocity
reserve (CFVR) may reflect important coronary pathophysiology but usually remains …

Background Bioresorbable vascular scaffolds were developed to overcome the
shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We …

Background—Acute ST-elevation myocardial infarction (STEMI) is caused by sudden
occlusive coronary thrombosis, after plaque disruption; however, a considerable time …

Background—Fractional flow reserve (FFR) and coronary blood flow velocity reserve (CFR)
represent physiological quantities used to evaluate coronary lesion severity and to make …

Background—Primary ventricular fibrillation (VF) accounts for the majority of deaths during
the acute phase of myocardial infarction. Identification of patients at risk for primary VF …

Objectives: This study sought to evaluate 30-day all-cause mortality of patients treated with
primary percutaneous coronary intervention (PCI) presenting with an acute myocardial …